Cargando…
Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer
Immunotherapeutic approaches have revolutionized the treatment of several diseases such as cancer. The main goal of immunotherapy for cancer is to modulate the anti-tumor immune responses by favoring the recognition and destruction of tumor cells. Recently, a better understanding of the suppressive...
Autores principales: | Bödder, Johanna, Zahan, Tasmin, van Slooten, Rianne, Schreibelt, Gerty, de Vries, I. Jolanda M., Flórez-Grau, Georgina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933030/ https://www.ncbi.nlm.nih.gov/pubmed/33679726 http://dx.doi.org/10.3389/fimmu.2020.631713 |
Ejemplares similares
-
Human Dendritic Cell Subset Isolation by Magnetic Bead Sorting: A Protocol to Efficiently Obtain Pure Populations
por: Flórez-Grau, Georgina, et al.
Publicado: (2023) -
Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion
por: Le Gall, Camille, et al.
Publicado: (2022) -
Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated Monocyte-Derived DCs to Naturally Circulating DC Subsets
por: Wimmers, Florian, et al.
Publicado: (2014) -
Tailored PGE2 Immunomodulation of moDCs by Nano-Encapsulated EP2/EP4 Antagonists
por: Bödder, Johanna, et al.
Publicado: (2023) -
Human type 1 and type 2 conventional dendritic cells express indoleamine 2,3‐dioxygenase 1 with functional effects on T cell priming
por: Sittig, Simone P., et al.
Publicado: (2021)